C Toumpanakis
Overview
Explore the profile of C Toumpanakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsoli M, Wilson H, Armonis P, Kamieniarz L, Thuringer J, Mirnezami R, et al.
J Endocrinol Invest
. 2024 Mar;
47(9):2295-2303.
PMID: 38451399
Purpose: Peritoneal metastases (PM) of neuroendocrine neoplasm (NEN) origin are identified with increasing frequency and exert a significant effect on quality of life and clinical status of the patients. The...
2.
Borbath I, Pape U, Deprez P, Bartsch D, Caplin M, Falconi M, et al.
J Neuroendocrinol
. 2022 Mar;
34(3):e13105.
PMID: 35233848
Despite efforts from various endoscopy societies, reporting in the field of endoscopy remains extremely heterogeneous. Harmonisation of clinical practice in endoscopy has been highlighted by application of many clinical practice...
3.
Modlin I, Kidd M, Falconi M, Filosso P, Frilling A, Malczewska A, et al.
Ann Oncol
. 2021 Aug;
32(11):1425-1433.
PMID: 34390828
Background: Biomarkers are key tools in cancer management. In neuroendocrine tumors (NETs), Chromogranin A (CgA) was considered acceptable as a biomarker. We compared the clinical efficacy of a multigenomic blood...
4.
Oberg K, Califano A, Strosberg J, Ma S, Pape U, Bodei L, et al.
Ann Oncol
. 2020 Jan;
31(2):202-212.
PMID: 31959337
Background: The lack of an accurate blood biomarker in neuroendocrine tumor (NET) disease has hindered management. The advance of genomic medicine and the development of molecular biomarkers has provided a...
5.
Valente R, Lykoudis P, Tamburrino D, Inama M, Passas I, Toumpanakis C, et al.
Eur J Surg Oncol
. 2017 Aug;
43(11):2119-2128.
PMID: 28821361
Background: The oncological impact of surgical complications has been studied in visceral and pancreatic cancer. Aim: To investigate the impact of complications on tumour recurrence after resections for pancreatic neuroendocrine...
6.
Fenning S, Newby D, Toumpanakis C, Strachan M
QJM
. 2016 Mar;
109(7):483-4.
PMID: 27016533
No abstract available.
7.
Niederle B, Pape U, Costa F, Gross D, Kelestimur F, Knigge U, et al.
Neuroendocrinology
. 2016 Jan;
103(2):125-38.
PMID: 26758972
No abstract available.
8.
Garcia-Carbonero R, Sorbye H, Baudin E, Raymond E, Wiedenmann B, Niederle B, et al.
Neuroendocrinology
. 2016 Jan;
103(2):186-94.
PMID: 26731334
No abstract available.
9.
Pape U, Niederle B, Costa F, Gross D, Kelestimur F, Kianmanesh R, et al.
Neuroendocrinology
. 2016 Jan;
103(2):144-52.
PMID: 26730583
No abstract available.
10.
Khan M, Luong T, Watkins J, Toumpanakis C, Caplin M, Meyer T
Br J Cancer
. 2013 Apr;
108(9):1838-45.
PMID: 23579216
Background: The aim of this study was to compare mitotic count (MC) and Ki-67 proliferation index as prognostic markers in pancreatic and midgut neuroendocrine neoplasms (NENs). Methods: Two hundred eighty-five...